Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 3,600 | 0 | 0 | 0 | 0 |
| Gross Profit | 3,600 | N/A | N/A | N/A | N/A |
| Operating Expenses | 33,839 | 33,940 | 41,037 | 44,025 | 38,133 |
| Operating Income | -30,239 | -33,940 | -41,037 | -44,025 | -38,133 |
| Other Income | 1,200 | 1,223 | 923 | 283 | 244 |
| Pre-tax Income | -29,039 | -32,717 | -40,114 | -43,742 | -37,889 |
| Income Tax | 17 | 19 | 17 | 19 | 19 |
| Net Income Continuous | -29,056 | -32,736 | -40,131 | -43,761 | -37,908 |
| Net Income | $-29,056 | $-32,736 | $-40,131 | $-43,761 | $-37,908 |
| EPS Basic Total Ops | -2.90 | -3.40 | -4.00 | -4.40 | -3.80 |
| EPS Basic Continuous Ops | -2.90 | -3.27 | -4.03 | -4.42 | -3.84 |
| EPS Diluted Total Ops | -2.90 | -3.40 | -4.00 | -4.40 | -3.80 |
| EPS Diluted Continuous Ops | -2.90 | -3.27 | -4.03 | -4.42 | -3.84 |
| EPS Diluted Before Non-Recurring Items | -2.90 | -3.30 | -4.00 | -4.40 | N/A |
| EBITDA(a) | $-29,607 | $-32,831 | $-39,784 | $-42,376 | $-36,496 |